A critical analysis of the prognostic performance of the 8th edition American Joint Committee on Cancer staging for metastatic cutaneous squamous cell carcinoma of the head and neck.
Ashish SoodJames WykesDavid RoshanLaura Y WangJohn McGuinnessAllan FowlerArdalan EbrahimiPublished in: Head & neck (2019)
The majority of patients with metastatic cSCCHN have ENE and are classified as TNM stage IV based on the 8th edition staging, resulting in poor prognostic performance.